Published: October 16, 2025 at 9:30 am
Wild Bioscience, an Oxford University spinout that develops improved crop varieties using AI and precision breeding, has raised a £45 million Series A investment.
The funding round was led by the Ellison Institute of Technology (EIT), founded by Larry Ellison, CTO and chairman of Oracle.
Existing investors Oxford Science Enterprises (OSE), Braavos Capital and the University of Oxford also participated in the round.
The company started life in the University of Oxford with Founders Dr Ross Hendron and Prof. Steve Kelly, who spun out the business in 2021 to translate their scientific research out of the lab and onto the farm.
Ellison said: “Wild Bio is using AI to better understand the lessons learned over millions of years of evolution encoded in plant genomes.
“Those insights combined with precision breeding has enabled Wild Bio to develop new varieties of crops with both higher yields and climate resilience.
“The ultimate goal is to grow these new crop varieties on a commercial scale and help provide food security around the world. EIT is committed to working with Wild Bio to reach this goal.”